Close Menu

NEW YORK – The Foundation for Innovative New Diagnostics announced on Thursday it has signed a $14.5 million deal with Unitaid to evaluate using next-generation sequencing for diagnosing drug-resistant tuberculosis in low- and middle-income nations.

Over three years, starting in October, the project, called Seq&Treat, will be implemented in Brazil, China, Georgia, India, and South Africa. The project, FIND said, will enable the introduction and adoption of targeted NGS technology for affordable, scalable, and rapid TB drug-susceptibility testing.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Genetic genealogy has helped exonerate a man who has been jailed for 20 years, Agence France Presse reports.

NPR reports that many USDA researchers working at the two agencies that are relocating to the Kansas City area are declining to go.

A new report says genetically modified food might be necessary to be able to feed a planet of nearly 10 billion people, Bloomberg says.

In Nature this week: new RNA editing approach called LEAPER, draft assembly of Musa balbisiana banana genome, and more.

Aug
28
Sponsored by
Horizon Discovery

This webinar will provide an overview of alternatives to the popular Cas9 nuclease used in CRISPR gene editing.